menu
    • menu

    Looking for Carbomer Homopolymer Type A pharmaceutical excipients? Find information on Carbomer Homopolymer Type A's applications, manufacturers, suppliers, etc. on PharmaCompass.

    Client Email Product
    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Evonik

    Virtual Booth

    Contact Supplier

    Gensenta is a trusted CDMO partner with robust history, commitment to quality, innovative mindset and commitment to sustainability.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    INACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    EXCIPIENTS BY APPLICATIONS

    MARKET PLACE

    PharmaCompass

    Chemistry

    Click the arrow to open the dropdown
    read-moreClick the button for full data set
    read-moreClick the button for full data set
    Also known as: Carbopol 71g nf
    Carbomer Homopolymer is a high molecular weight polymer of acrylic acid cross-linked with allyl ethers of polyalcohols. Carbomer Homopolymer, previously dried, contains not less than 56.0 percent and not more than 68.0 percent of carboxylic acid groups. Ethyl acetate is used as residual solvent in the production of carbomer homopolymer type A. It acts as rheology modifiers or controlled release agents in liquid, semisolid and solid dosage forms.

    SUPPLIERS

    read-more
    read-more

    01

    Lubrizol Life Science Health

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    FNCE 2024
    Not Confirmed
    arrow

    Lubrizol Life Science Health

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    FNCE 2024
    Not Confirmed
    USDMF arrow-down Click Us! arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 33897

    Submission : 2019-05-31

    Status : Active

    Type : IV

     CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    FINISHED DOSAGE FORMULATIONS

    Upload your portfolio for free, ask us

    FDF DOSSIERS SUPPLIERS

    read-more
    read-more

    01

    WATSON LABS INC
    Ireland
    arrow
    ASC 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    NITROFURANTOIN; NITROFURANTOIN, MACROCRYSTALLINE

    Drug : NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)

    Dosage Form : CAPSULE; ORAL

    Application Number : 202250

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    AUROBINDO PHARMA LTD

    METFORMIN HYDROCHLORIDE

    arrow
    ASC 2024
    Not Confirmed
    AUROBINDO PHARMA LTD
    India
    arrow
    ASC 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    METFORMIN HYDROCHLORIDE

    Drug : METFORMIN HYDROCHLORIDE

    Dosage Form : TABLET, EXTENDED RELEASE; ORAL

    Application Number : 79118

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    BAUSCH

    CLINDAMYCIN PHOSPHATE

    arrow
    ASC 2024
    Not Confirmed
    BAUSCH
    Canada
    arrow
    ASC 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    CLINDAMYCIN PHOSPHATE

    Drug : CLINDAGEL

    Dosage Form : GEL; TOPICAL

    Application Number : 50782

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    GALDERMA LABS LP

    ADAPALENE

    arrow
    ASC 2024
    Not Confirmed
    GALDERMA LABS LP
    U.S.A
    arrow
    ASC 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    ADAPALENE

    Drug : DIFFERIN

    Dosage Form : LOTION; TOPICAL

    Application Number : 22502

    Country : US

    Patented : Yes

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    INVENTIA

    PALIPERIDONE

    arrow
    ASC 2024
    Not Confirmed
    INVENTIA
    India
    arrow
    ASC 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    PALIPERIDONE

    Drug : PALIPERIDONE

    Dosage Form : TABLET, EXTENDED RELEASE; ORAL

    Application Number : 204452

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    LANNETT CO INC

    DIETHYLPROPION HYDROCHLORIDE

    arrow
    ASC 2024
    Not Confirmed
    LANNETT CO INC
    U.S.A
    arrow
    ASC 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    DIETHYLPROPION HYDROCHLORIDE

    Drug : DIETHYLPROPION HYDROCHLORIDE

    Dosage Form : TABLET, EXTENDED RELEASE; ORAL

    Application Number : 91680

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    LEO PHARMA AS

    DESONIDE

    arrow
    ASC 2024
    Not Confirmed
    LEO PHARMA AS
    Denmark
    arrow
    ASC 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    DESONIDE

    Drug : DESONATE

    Dosage Form : GEL; TOPICAL

    Application Number : 21844

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    ZYDUS LIFESCIENCES

    SILDENAFIL CITRATE

    arrow
    ASC 2024
    Not Confirmed
    ZYDUS LIFESCIENCES
    India
    arrow
    ASC 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    SILDENAFIL CITRATE

    Drug : SILDENAFIL CITRATE

    Dosage Form : FOR SUSPENSION; ORAL

    Application Number : 215708

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    EXCIPIENTS BY APPLICATIONS

    Click here to find the perfect excipient manufacturers by their capabilities